Bioventus Inc. (BVS) Social Stream



Bioventus Inc. (BVS): $2.09

-0.02 (-0.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BIOVENTUS INC (BVS) Price Targets From Analysts

Use the tables below to see what analysts covering BIOVENTUS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-03-08 1 $23 $23 $23 $2.11 990.05%
2021-11-10 3 $25 $23 $24 $2.11 1037.44%
2022-01-25 3 $25 $20 $22.666 $2.11 974.22%
2022-05-11 3 $30 $18 $23 $2.11 990.05%
2022-07-14 3 $30 $11 $20.666 $2.11 879.43%
2022-08-12 3 $30 $12 $18 $2.11 753.08%
2022-09-07 4 $30 $12 $16.75 $2.11 693.84%
2022-10-11 4 $30 $11 $16.5 $2.11 681.99%
2022-11-09 3 $10 $5 $7 $2.11 231.75%
2022-11-30 4 $10 $2.5 $5.875 $2.11 178.44%

The Trend in the Analyst Price Target


Over the past 29 weeks, BVS's average price target has gone down $17.12.

Over the past 37 weeks, BVS's average upside potential has been 161.03%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-15 3 30 18 23.0 13.45 71%
2022-04-11 3 30 18 23.0 12.90 78.29%
2022-08-12 3 30 12 18.0 9.08 98.24%
2022-10-11 4 30 11 16.5 6.71 145.9%
2022-11-09 4 13 5 8.5 2.58 229.46%

BVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.5 0 0 3 1 1 4

The Trend in the Broker Recommendations


Over the past 35 weeks, BVS's average broker recommendation rating worsened by 2.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • BIOVENTUS INC's upside potential (average analyst target price relative to current price) is higher than 1602.34% of all US stocks.
  • In the context of all US stocks, BIOVENTUS INC's number of analysts covering the stock is greater than 198.21% of them.
  • To contextualize these metrics, consider that out of all US stocks, BIOVENTUS INC's variance in analysts' estimates is lower than -901.46% of them.
  • In the context of Medical Equipment stocks, BIOVENTUS INC's average analyst price target is greater than 416.19% of them.

In the Medical Equipment industry, NPCE, TMCI, and CVRX are the three stocks most similar to BIOVENTUS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for BVS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8272 seconds.